Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)

This study has been completed.
Sponsor:
Collaborators:
Arizona State University
Friends Research Institute, Inc.
National Development and Research Institutes, Inc.
Temple University
Texas Christian University
University of California, Los Angeles
University of Connecticut
University of Delaware
University of Kentucky
University of Puerto Rico
Information provided by (Responsible Party):
Peter D. Friedmann, Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT01344122
First received: April 21, 2011
Last updated: June 18, 2014
Last verified: June 2014
  Purpose

The goal of this study is to see whether or not a strategic planning process is able to introduce and sustain improvements in the working relationship between probation/parole departments and community-based addiction treatment agencies that provide medication assisted therapy (MAT) for individuals with opioid or alcohol dependence. In addition, this study seeks to improve probation/parole agency personnel's knowledge and perceptions about MAT, and increase the number of appropriate referrals to community treatment agencies that provide MAT. There are three phases to this study. Phase 1 includes a pilot study to determine the quality and availability of client level records and the collection of baseline data (the pilot study protocol was previously submitted to TMH IRB). Phase 2 will consist of a Knowledge, Perceptions and Information (KPI) intervention during which probation/parole agencies will undergo training to increase knowledge about the effectiveness of MAT, and complete a post training assessment to evaluate the effectiveness of the KPI intervention. During Phase 3, probation/parole agencies will be randomly assigned to a 12-month Organizational Linkage Intervention (OLI) condition or to control (no further intervention). Agencies assigned to the OLI will establish a Pharmacotherapy Exchange Council (PEC) that consists of staff from both the probation/parole and community treatment agencies. The PEC will undergo a strategic planning process to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole.


Condition Intervention
Opioid-Related Disorders
Alcohol-Related Disorders
Other: KPI training only
Other: KPI plus OLI

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)

Further study details as provided by Rhode Island Hospital:

Primary Outcome Measures:
  • Referrals to Medication Assisted Treatment (MAT) [ Time Frame: 6-Month Follow-up ] [ Designated as safety issue: No ]
    Estimated numbers of alcohol- and opiate-dependent offenders on Probation/Parole caseloads, and the extent to which MAT-eligible clients are referred to an MAT provider. Will be assessed at baseline, post training, post intervention, and 6-month follow-up.

  • Interorganizational Relationships [ Time Frame: 6-month follow-up ] [ Designated as safety issue: No ]
    Measures relationships between the different organizations participating in MATICCE. Will be assessed at baseline, and post intervention (6-month follow-up).

  • Opinions About MAT [ Time Frame: 6-month follow-up ] [ Designated as safety issue: No ]
    Measures knowledge, perceptions, and intentions regarding the use of pharmacotherapy for the treatment of opioid and alcohol dependence. Will be assessed at baseline, post-training, post intervention, and 6-month follow-up.


Enrollment: 20
Study Start Date: October 2010
Study Completion Date: September 2013
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: KPI training only Other: KPI training only
Study sites randomized to this arm will receive a knowledge, perceptions and information (KPI) training for community correctional and treatment staff to address knowledge, perceptions, and information regarding local resources about MAT.
Experimental: KPI plus OLI Other: KPI plus OLI
Study sites randomized to this arm will receive the KPI training plus a Organizational Linkage Intervention (OLI) that will: (a) establish a local Pharmacotherapy Exchange Council (PEC) among agencies important for the implementation of MAT in community corrections; (b) facilitate a strategic planning process within the PEC to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole; and (c) identify a community corrections coordinator in one of the local agencies to operationalize and implement the strategic plan.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Probation/parole or community treatment agency staff.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01344122

Sponsors and Collaborators
Rhode Island Hospital
Arizona State University
Friends Research Institute, Inc.
National Development and Research Institutes, Inc.
Temple University
Texas Christian University
University of California, Los Angeles
University of Connecticut
University of Delaware
University of Kentucky
University of Puerto Rico
Investigators
Principal Investigator: Peter D Friedmann, MD, MPH Rhode Island Hospital
  More Information

No publications provided

Responsible Party: Peter D. Friedmann, Professor, Rhode Island Hospital
ClinicalTrials.gov Identifier: NCT01344122     History of Changes
Other Study ID Numbers: CJDATS2-001, U01DA016191
Study First Received: April 21, 2011
Last Updated: June 18, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Opioid-Related Disorders
Alcohol-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 28, 2014